Editorial companion

What stands out

Merck jumped to fresh highs after data showed its personalized cancer vaccine, used with Keytruda, cut melanoma recurrence, while Moderna rebounded from a one-day rout and Ross Stores raised its earnings per share (EPS) outlook on better-than-expected traffic and comp sales. Bloomberg’s clip bundles three very different market moves: a biotech binary reprice, a high-volatility recovery trade, and an off-price retailer getting paid for bringing in new customers. For investors, it is a reminder that headlines can reallocate risk and sentiment across sectors in a single session.